FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.
Musa YlimazNaval G DaverGautam BorthakurTapan Mahendra KadiaCourtney D D DiNardoRashmi Kanagal-ShamanaSanam LoghaviBetul OranUday R PopatSherry PierceElias J JabbourNicholas James ShortGhayas IssaMaro Ohanian DOMarina Y KonoplevaKeyur PatelHagop KantarjianFarhad RavandiPublished in: American journal of hematology (2021)
Keyphrases
- acute myeloid leukemia
- newly diagnosed
- stem cells
- stem cell transplantation
- allogeneic hematopoietic stem cell transplantation
- bone marrow
- disease activity
- hematopoietic stem cell
- risk factors
- ulcerative colitis
- rheumatoid arthritis
- systemic lupus erythematosus
- tyrosine kinase
- cell therapy
- metabolic syndrome
- weight loss